Lung Science Conference highlights 2023: Post-viral lung diseases – from basic immunology to clinical phenotypes and therapy

IF 2.3 Q2 RESPIRATORY SYSTEM Breathe Pub Date : 2023-09-01 DOI:10.1183/20734735.0169-2023
Sara Cuevas Ocaña, Chiara DeSanti, Katie Daly, Christina Shrees, Nimród László, Carla Bellinghausen, Carola Voss, Joana Cruz
{"title":"Lung Science Conference highlights 2023: Post-viral lung diseases – from basic immunology to clinical phenotypes and therapy","authors":"Sara Cuevas Ocaña, Chiara DeSanti, Katie Daly, Christina Shrees, Nimród László, Carla Bellinghausen, Carola Voss, Joana Cruz","doi":"10.1183/20734735.0169-2023","DOIUrl":null,"url":null,"abstract":"This article provides an overview of some of the highlights of the Lung Science Conference 2023 https://bit.ly/46oWCEX","PeriodicalId":9292,"journal":{"name":"Breathe","volume":"96 1","pages":"0"},"PeriodicalIF":2.3000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breathe","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/20734735.0169-2023","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

This article provides an overview of some of the highlights of the Lung Science Conference 2023 https://bit.ly/46oWCEX
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2023年肺科学会议亮点:病毒性后肺部疾病-从基本免疫学到临床表型和治疗
本文概述了2023年肺科学会议https://bit.ly/46oWCEX的一些亮点
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Breathe
Breathe RESPIRATORY SYSTEM-
CiteScore
2.90
自引率
5.00%
发文量
51
审稿时长
12 weeks
期刊最新文献
A 69-year-old man with generalised lymphadenopathy, glandular swelling and pleural effusion. Cardiopulmonary disease. Developments in the field of respiratory nursing in Türkiye. Extracorporeal membrane oxygenation for adults with respiratory failure secondary to cardiorespiratory disease: evolving indications and clinical practice. From basic scientific research to the development of new drugs for pulmonary arterial hypertension: insights from activin-targeting agents.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1